Binding of spirolactones to human plasma proteins.
The lipophilicity and plasma binding of 16 spirolactones and 4 hydroxy acid analogs were determined. Mathematical expressions were derived to correlate quantitatively the extent of plasma binding to the lipophilicity of the drugs. The nonspecific binding of these spirolactones and their hydroxy acid analogs was also analyzed using purified serum albumin. A computer program was developed to examine the mechanism of drug-serum protein interactions. One class of binding sites was observed for the range of concentrations used. The number of binding sites and the equilibrium binding constant were computed and were sensitive to substitution at the C-6 and C7 positions. Hydrolysis of the C-17 lactone ring in spirolactones to form hydroxy acid analogs resulted in a decrease in the lipophilicity and, hence, the equilibrium constant for binding.
D001665:Binding Sites; D011485:Protein Binding; D012709:Serum Albumin / Q000378:metabolism*; D013148:Spironolactone / Q000031:analogs & derivatives* / Q000097:blood; D013329:Structure-Activity Relationship
D012709:Serum Albumin; D013148:Spironolactone